BFOCX
Price
$50.76
Change
+$0.92 (+1.85%)
Updated
Aug 7 closing price
Net Assets
361.55M
PRGTX
Price
$35.31
Change
+$0.66 (+1.90%)
Updated
Aug 7 closing price
Net Assets
8.35B
Interact to see
Advertisement

BFOCX vs PRGTX

BFOCX vs PRGTX Comparison Chart in %
View a ticker or compare two or three
VS
BFOCX vs. PRGTX commentary
Aug 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFOCX is a Buy and PRGTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 8.35B vs. BFOCX (362M). BFOCX (0.00) and PRGTX (0.00) have matching dividends . BFOCX was incepted earlier than PRGTX: BFOCX (29 years) vs PRGTX (26 years). BFOCX (1.95) is less costly to investors than PRGTX (0.93). BFOCX is a more actively managed with annual turnover of: 2603.80 vs. PRGTX (34.60). PRGTX has a lower initial minimum investment than BFOCX: PRGTX (2500) vs BFOCX (5000). PRGTX annual gain was more profitable for investors over the last year : 46.27 vs. BFOCX (31.60). BFOCX return over 5 years is better than : 18.13 vs. PRGTX (9.45).
BFOCXPRGTXBFOCX / PRGTX
Total Expense Ratio1.950.93210%
Annual Report Gross Expense Ratio1.950.93210%
Fund Existence29 years26 years-
Gain YTD30.45532.99492%
Front LoadN/AN/A-
Min. Initial Investment50002500200%
Min. Initial Investment IRAN/AN/A-
Net Assets362M8.35B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year31.6046.2768%
Returns for 3 years188.08151.68124%
Returns for 5 years18.139.45192%
Returns for 10 years187.59142.68131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEGIX40.870.41
+1.01%
Invesco Discovery Mid Cap Growth R6
NOSGX12.440.09
+0.73%
Northern Small Cap Value
THOVX54.610.33
+0.61%
Thornburg Global Opportunities R4
BIDEX12.180.05
+0.41%
BlackRock Defensive Advantage EM Instl
SCRUX12.790.05
+0.39%
Invesco Income Advantage U.S. Fund R